DK58285D0 - Peptider samt fremstilling og anvendelse deraf - Google Patents

Peptider samt fremstilling og anvendelse deraf

Info

Publication number
DK58285D0
DK58285D0 DK58285A DK58285A DK58285D0 DK 58285 D0 DK58285 D0 DK 58285D0 DK 58285 A DK58285 A DK 58285A DK 58285 A DK58285 A DK 58285A DK 58285 D0 DK58285 D0 DK 58285D0
Authority
DK
Denmark
Prior art keywords
chain
human insulin
bridging
insulin
lys
Prior art date
Application number
DK58285A
Other languages
Danish (da)
English (en)
Inventor
-Unknown
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK58285(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK266584A external-priority patent/DK266584D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK58285A priority Critical patent/DK58285D0/da
Publication of DK58285D0 publication Critical patent/DK58285D0/da
Priority to GR851304A priority patent/GR851304B/el
Priority to NO852132A priority patent/NO174351C/no
Priority to PT80551A priority patent/PT80551B/pt
Priority to DE3588125T priority patent/DE3588125T2/de
Priority to DK238585A priority patent/DK157938C/da
Priority to IE950351A priority patent/IE80630B1/en
Priority to AT90121887T priority patent/ATE143374T1/de
Priority to EP85303775A priority patent/EP0163529B1/fr
Priority to FI852135A priority patent/FI89183C/fi
Priority to JP60116297A priority patent/JPH0630613B2/ja
Priority to IE133185A priority patent/IE66387B1/en
Priority to AT85303775T priority patent/ATE66490T1/de
Priority to DE8585303775T priority patent/DE3583824D1/de
Priority to US06/739,123 priority patent/US4916212A/en
Priority to ES543594A priority patent/ES8609483A1/es
Priority to AU43092/85A priority patent/AU590197B2/en
Priority to NZ212243A priority patent/NZ212243A/en
Priority to EP90121887A priority patent/EP0427296B1/fr
Priority to CA000482722A priority patent/CA1304022C/fr
Priority to ES551941A priority patent/ES8702488A1/es
Priority to DK323687A priority patent/DK157933C/da
Priority to JP5121694A priority patent/JPH0746998B2/ja
Priority to JP5121649A priority patent/JPH07121226B2/ja
Priority to JP7142085A priority patent/JP2519023B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK58285A 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf DK58285D0 (da)

Priority Applications (25)

Application Number Priority Date Filing Date Title
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf
GR851304A GR851304B (fr) 1984-05-30 1985-05-28
NZ212243A NZ212243A (en) 1984-05-30 1985-05-29 Yeast strains expressing modified recombinant insulin
EP90121887A EP0427296B1 (fr) 1984-05-30 1985-05-29 Précurseurs d'insuline
CA000482722A CA1304022C (fr) 1984-05-30 1985-05-29 Precurseurs de l'insuline, procede de preparation et procede de preparation d'insuline a partir de ces precurseurs de l'insuline
JP60116297A JPH0630613B2 (ja) 1984-05-30 1985-05-29 インシュリンの製造方法
DE8585303775T DE3583824D1 (de) 1984-05-30 1985-05-29 Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
DE3588125T DE3588125T2 (de) 1984-05-30 1985-05-29 Insulin-Vorläufer
DK238585A DK157938C (da) 1984-05-30 1985-05-29 Dna-sekvens for insulinprecursorer, vektorer indeholdende denne sekvens, gaerstammer transformeret med disse vektorer samt en fremgangsmaade til fremstilling af insulinprecursorerne og en fremgangsmaade til fremstilling af humaninsulin
IE950351A IE80630B1 (en) 1984-05-30 1985-05-29 Insulin precursors
AT90121887T ATE143374T1 (de) 1984-05-30 1985-05-29 Insulin-vorläufer
EP85303775A EP0163529B1 (fr) 1984-05-30 1985-05-29 Précurseurs d'insuline, procédé pour leur production et procédé pour la production d'insuline humaine à partir de tels précurseurs d'insuline
FI852135A FI89183C (fi) 1984-05-30 1985-05-29 Dna-sekvens som kodar foer insulinprekursorer, vektorer innehaollande denna sekvens, insulinprekursorer och foerfarande foer framstaellning av dessa samt foerfarande foer framstaellning av humaninsulin
NO852132A NO174351C (no) 1984-05-30 1985-05-29 Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
IE133185A IE66387B1 (en) 1984-05-30 1985-05-29 Insulin precursors process for their preparation and process for preparing human insulin from such insulin precursors
AT85303775T ATE66490T1 (de) 1984-05-30 1985-05-29 Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
PT80551A PT80551B (en) 1984-05-30 1985-05-29 Process for the preparation of insulin precursors useful for preparing human insulin
US06/739,123 US4916212A (en) 1984-05-30 1985-05-29 DNA-sequence encoding biosynthetic insulin precursors and process for preparing the insulin precursors and human insulin
ES543594A ES8609483A1 (es) 1984-05-30 1985-05-29 Un procedimiento para producir un precursor de insulina
AU43092/85A AU590197B2 (en) 1984-05-30 1985-05-29 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
ES551941A ES8702488A1 (es) 1984-05-30 1986-02-13 Un procedimiento para preparar un precursor de insulina
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer
JP5121649A JPH07121226B2 (ja) 1984-05-30 1993-05-24 インシュリン前駆体をコードするｄｎａ
JP5121694A JPH0746998B2 (ja) 1984-05-30 1993-05-24 インシュリン前駆体の製造方法
JP7142085A JP2519023B2 (ja) 1984-05-30 1995-06-08 インシュリン前駆体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK266584A DK266584D0 (da) 1984-05-30 1984-05-30 Dna-sekvens, der koder for en biosyntetisk insulinprecursor og fremgangsmaade til fremstilling af insulinprecursoren
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf

Publications (1)

Publication Number Publication Date
DK58285D0 true DK58285D0 (da) 1985-02-08

Family

ID=26064247

Family Applications (2)

Application Number Title Priority Date Filing Date
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer

Country Status (15)

Country Link
US (1) US4916212A (fr)
EP (2) EP0163529B1 (fr)
JP (4) JPH0630613B2 (fr)
AT (1) ATE143374T1 (fr)
AU (1) AU590197B2 (fr)
CA (1) CA1304022C (fr)
DE (2) DE3583824D1 (fr)
DK (2) DK58285D0 (fr)
ES (2) ES8609483A1 (fr)
FI (1) FI89183C (fr)
GR (1) GR851304B (fr)
IE (1) IE66387B1 (fr)
NO (1) NO174351C (fr)
NZ (1) NZ212243A (fr)
PT (1) PT80551B (fr)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
ATE101620T1 (de) * 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
CA2089541A1 (fr) 1992-02-18 1993-08-19 Bruce H. Frank Elimination selective d'extensions terminales en n dans des precurseurs d'insuline replies, grace a la dipeptidyl-aminopeptidase-1
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
CN1182451A (zh) 1995-03-17 1998-05-20 诺沃挪第克公司 新的内切葡聚糖酶
WO1996034882A1 (fr) * 1995-05-05 1996-11-07 Eli Lilly And Company Insuline monocatenaire a bioactivite elevee
GB9513967D0 (en) * 1995-07-08 1995-09-06 Univ Leicester Insulin
US5840542A (en) * 1995-07-28 1998-11-24 Mogam Biotechnology Research Institute Method for manufacture of proinsulin with high export yield
DK1975177T3 (da) 1996-03-01 2011-07-25 Novo Nordisk As Appetitundertrykkende peptid, formuleringer dermed og anvendelse deraf
IL138658A0 (en) * 1998-03-31 2001-10-31 Tonghua Gantech Biotechnology Chimeric protein
CN1125081C (zh) 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
JP2003530316A (ja) 1999-12-22 2003-10-14 ノボ ノルディスク アクティーゼルスカブ スクランブルした一本鎖ポリペプチドの抽出的再生法
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
CN1415019A (zh) 1999-12-29 2003-04-30 诺沃挪第克公司 用于生产在酵母中具有改进发酵产量的胰岛素前体和胰岛素前体类似物的方法
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
WO2001049742A1 (fr) * 1999-12-29 2001-07-12 Novo Nordisk A/S Procede de production de precurseurs d'insuline et d'analogues de precurseurs d'insuline
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
JP2003528149A (ja) 2000-03-24 2003-09-24 ジェネンテック・インコーポレーテッド 軟骨性疾患の治療のためのインスリンの使用
EP2267026A1 (fr) 2000-04-12 2010-12-29 Human Genome Sciences, Inc. Protéine de fusion d'albumine
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
PL371800A1 (en) 2001-03-22 2005-06-27 Novo Nordisk Health Care Ag Coagulation factor vii derivatives
ATE443082T1 (de) * 2001-04-02 2009-10-15 Novo Nordisk As Insulinvorstufen und verfahren zu deren herstellung
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
CA2446739A1 (fr) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Proteines hybrides beta-1 de chimiokine
ES2376694T3 (es) 2001-09-27 2012-03-16 Novo Nordisk Health Care Ag Polipã‰ptidos del factor vii de coagulaciã“n humano.
WO2005003296A2 (fr) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Proteines hybrides d'albumine
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
AU2003255988A1 (en) * 2002-09-13 2004-04-30 Edupuganti B. Raju Yeast protein expression secretion system
CA2925807C (fr) 2002-09-13 2020-09-15 Cornell Research Foundation, Inc. Utilisation de mutations pour ameliorer les aspergillus phytases
WO2004085472A1 (fr) * 2003-03-27 2004-10-07 Novo Nordisk A/S Procede de fabrication de precurseurs de l'insuline humaine et insuline humaine
DK1633876T3 (da) 2003-06-17 2008-12-08 Sembiosys Genetics Inc Fremgangsmåde til fremstilling af insulin i planter
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
JP2007532096A (ja) * 2003-11-14 2007-11-15 ノボ　ノルディスク　アクティーゼルスカブ アシル化されたインスリンの製造方法
ATE517119T1 (de) * 2003-12-03 2011-08-15 Novo Nordisk As Einzelketteninsulin
EP2256130B1 (fr) 2005-02-02 2013-09-25 Novo Nordisk A/S Nouveaux dérivés d'insuline
JP5410020B2 (ja) 2005-02-02 2014-02-05 ノヴォ ノルディスク アー／エス インスリン誘導体
US8034326B2 (en) 2005-04-18 2011-10-11 Novo Nordisk A/S IL-21 variants
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
US20090055942A1 (en) 2005-09-14 2009-02-26 Novo Nordisk Healthcare A/G Human Coagulation Factor VII Polypeptides
JP2009530243A (ja) * 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー／エス アシル化単鎖インスリン
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
WO2008037735A1 (fr) 2006-09-27 2008-04-03 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
JP5404411B2 (ja) 2006-11-22 2014-01-29 ノボ・ノルデイスク・エー／エス 活性化カルボキシペプチダーゼの製造方法
US7790677B2 (en) * 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
KR20100053561A (ko) 2007-08-15 2010-05-20 노보 노르디스크 에이/에스 아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
JP5721432B2 (ja) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー／エス アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
CN101605889A (zh) * 2008-02-12 2009-12-16 伊藤火腿株式会社 含有高表达分泌胰岛素前体的融合蛋白、编码该融合蛋白的dna和胰岛素的制备方法
US9242011B2 (en) 2008-04-01 2016-01-26 Novo Nordisk A/S Insulin albumin conjugates
US20120107267A1 (en) 2009-03-11 2012-05-03 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
EP2340033B1 (fr) 2009-06-26 2013-10-09 Novo Nordisk A/S Préparation contenant de l'insuline, du nicotinamide et de l'arginine
EP3395828A1 (fr) 2009-07-17 2018-10-31 Rigshospitalet Inhibiteurs d'activation complémentaire
WO2011067283A1 (fr) 2009-12-01 2011-06-09 Novo Nordisk A/S Nouvelles peptidyl a-hydroxyglycine a-amide lyases
WO2011107591A1 (fr) 2010-03-05 2011-09-09 Rigshospitalet Molécules chimériques inhibitrices d'activation du complément
WO2011161083A1 (fr) 2010-06-23 2011-12-29 Novo Nordisk A/S Insuline humaine contenant des liaisons disulfures supplémentaires
KR20130036290A (ko) 2010-06-23 2013-04-11 노보 노르디스크 에이/에스 추가 이황화 결합을 함유하는 인슐린 유도체
EP2585484A1 (fr) * 2010-06-23 2013-05-01 Novo Nordisk A/S Analogues de l'insuline contenant des liaisons disulfures supplémentaires
JP2014501239A (ja) 2010-12-14 2014-01-20 ノヴォ ノルディスク アー／エス インスリン、ニコチンアミドおよびアミノ酸を含む製剤
WO2012080320A1 (fr) 2010-12-14 2012-06-21 Novo Nordisk A/S Insuline à action rapide en combinaison avec une insuline à longue durée d'action
US9187547B2 (en) 2011-03-15 2015-11-17 Novo Nordisk A/S Human insulin analogues and derivatives comprising cysteine substitutions
CN102675452B (zh) 2011-03-17 2015-09-16 重庆富进生物医药有限公司 具持续降血糖和受体高结合的人胰岛素及类似物的偶联物
WO2012171994A1 (fr) 2011-06-15 2012-12-20 Novo Nordisk A/S Insulines à substitutions multiples
JP6517018B2 (ja) 2012-02-09 2019-05-22 ヴァー２・ファーマシューティカルズ・アンパルトセルスカブＶＡＲ２ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ コンドロイチン硫酸グリカンのターゲティング
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
CN104704118A (zh) 2012-10-15 2015-06-10 诺和诺德保健Ag（股份有限公司） 凝血因子vii多肽
JP6735561B2 (ja) 2012-12-03 2020-08-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｏ−グリコシル化カルボキシ末端部分（ｃｔｐ）ペプチド系のインスリンおよびインスリン類似体
US9867869B2 (en) 2012-12-12 2018-01-16 Massachusetts Institute Of Technology Insulin derivatives for diabetes treatment
WO2014195452A1 (fr) 2013-06-07 2014-12-11 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
PL233560B1 (pl) 2014-12-05 2019-10-31 Mabion Spolka Akcyjna Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka
EA037848B1 (ru) 2016-07-14 2021-05-27 Общество С Ограниченной Ответственностью "Биохимический Агент" Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты)
US11230585B2 (en) 2016-09-06 2022-01-25 Chemical & Biopharmaceutical Laboratories Of Patra Proinsulin derivatives
RU2020108281A (ru) 2017-08-17 2021-08-26 Ново Нордиск А/С Новые ацилированные аналоги инсулина и варианты их применения
EP3821244A1 (fr) 2018-07-13 2021-05-19 Varct Diagnostics ApS Isolement de cellules circulantes d'origine foetale à l'aide d'une protéine de malaria recombinante var2csa
EP3845240A4 (fr) 2018-09-12 2021-11-03 Amphastar Nanjing Pharmaceuticals, Inc. Nouvelle structure de pro-insuline asparte et procédé de préparation d'insuline asparte
KR20220121833A (ko) 2019-12-30 2022-09-01 간 앤 리 파마슈티칼스 컴퍼니, 리미티드 인슐린 유도체
CA3166496A1 (fr) 2019-12-30 2021-07-08 Gan & Lee Pharmaceuticals Co., Ltd. Compose glp-1 a action prolongee
WO2022049409A1 (fr) 2020-09-02 2022-03-10 Sia Terragen Diagnostic express pour sars-cov-2
WO2023144240A1 (fr) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Dérivés d'insuline sensibles au glucose et leurs utilisations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440859A (en) * 1977-05-27 1984-04-03 The Regents Of The University Of California Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
US4431740A (en) * 1979-09-12 1984-02-14 The Regents Of The University Of California DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
IE50892B1 (en) * 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
RO81951B (ro) * 1980-03-27 1984-02-28 Eli Lilly And Company Procedeu de preparare a unui precursor de insulina
CA1202581A (fr) * 1980-03-27 1986-04-01 Saran A. Narang Molecules d'adaptation pour l'adn et application pour la synthese de produits derives de genes
ZA811895B (en) * 1980-04-07 1982-04-28 Univ California Expression of hormone genomic clones
JPS5750948A (en) * 1980-09-12 1982-03-25 Shionogi & Co Ltd Insulin analog and preparation
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1204682A (fr) * 1981-06-19 1986-05-20 Saran A. Narang Adapteurs, synthese et clonage des genes proinsuliniques
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
DK368882A (da) * 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
AU1559483A (en) * 1982-03-31 1983-10-24 Genetics Institute Inc. Creation of dna sequences encoding modified proinsulin precursors
WO1983003413A1 (fr) * 1982-03-31 1983-10-13 Genetics Inst Creation de sequences d'adn pour le codage de precurseurs modifies de pro-insuline
DK172738B1 (da) * 1983-04-07 1999-06-21 Chiron Corp Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
EP0243465A1 (fr) * 1985-10-25 1987-11-04 Vivian L. Mackay Procede d'utilisation de bar1 pour la secretion de proteines etrangeres

Also Published As

Publication number Publication date
ES8702488A1 (es) 1986-12-16
FI852135A0 (fi) 1985-05-29
FI89183C (fi) 1993-08-25
DK323687D0 (da) 1987-06-25
JPH06141865A (ja) 1994-05-24
EP0163529A1 (fr) 1985-12-04
NZ212243A (en) 1988-05-30
DK323687A (da) 1987-06-25
JPH0630613B2 (ja) 1994-04-27
IE66387B1 (en) 1995-12-27
NO174351B (no) 1994-01-10
JPH07309896A (ja) 1995-11-28
NO174351C (no) 1994-04-20
PT80551A (en) 1985-06-01
PT80551B (en) 1987-04-09
AU4309285A (en) 1985-12-05
EP0163529B1 (fr) 1991-08-21
AU590197B2 (en) 1989-11-02
ES8609483A1 (es) 1986-09-01
FI852135L (fi) 1985-12-01
ES551941A0 (es) 1986-12-16
NO852132L (no) 1985-12-02
DE3588125D1 (de) 1996-10-31
GR851304B (fr) 1985-11-25
ATE143374T1 (de) 1996-10-15
FI89183B (fi) 1993-05-14
EP0427296A1 (fr) 1991-05-15
IE851331L (en) 1985-11-30
JPH07121226B2 (ja) 1995-12-25
ES543594A0 (es) 1986-09-01
DK157933C (da) 1990-08-27
EP0427296B1 (fr) 1996-09-25
JP2519023B2 (ja) 1996-07-31
DE3583824D1 (de) 1991-09-26
JPH06141866A (ja) 1994-05-24
DE3588125T2 (de) 1997-02-13
CA1304022C (fr) 1992-06-23
US4916212A (en) 1990-04-10
JPS611389A (ja) 1986-01-07
DK157933B (da) 1990-03-05
JPH0746998B2 (ja) 1995-05-24

Similar Documents

Publication Publication Date Title
DK58285D0 (da) Peptider samt fremstilling og anvendelse deraf
NZ513422A (en) G-CSF analogues that do not possess any hematopoietic activity and are useful as antagonists against G-CSF effect, such as overproduction of G-CSF
DK336188D0 (da) Propeptider
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ES8802235A1 (es) Procedimiento para preparar un polipeptido
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
EP0195680A3 (fr) Synthèse de protéines avec un peptide d'identification
DE3380819D1 (en) A precursor of a c-terminal amidated peptide and production thereof
ES2044928T3 (es) Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo.
NZ216316A (en) Hepta and octapeptides with thymic humoral activity
ATE78872T1 (de) Herstellung von polypeptiden.
DK238585A (da) Peptider og fremstilling deraf
CA2047119A1 (fr) Traitement in vitro de proteines de fusion
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
EP0327360A3 (en) Novel polypeptides and dna encoding said polypeptides
EP0266006A3 (fr) Peptides hypotenseurs et diurétiques
DE3686036D1 (en) New fusion protein contg. small interleukin 2 ballast fragments
GB1210557A (en) Synthesis of polypeptides containing cysteine
CA1267086C (fr) Methode d'administration de peptides auriculaires diuretiques
DK301090A (da) Insulinprecursorer